Lumina Fund Management LLC Biogen Inc. Transaction History

Lumina Fund Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$193.77 - $244.14 $116,262 - $146,484	-600 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $335,880 - $431,655	-1,500 Reduced 71.43%	600 $144,000
Q2 2021 Aug 13, 2021	SELL	$259.0 - $414.71 $259,000 - $414,710	-1,000 Reduced 32.26%	2,100 $727,000
Q4 2020 Feb 12, 2021	BUY	$236.26 - $355.63 $732,406 - $1.1 Million	3,100 New	3,100 $759,000

1,036

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Lumina Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lumina Fund Management LLC with notifications on news.